Prosight Management, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $372 Million distributed in 47 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adc Therapeutics Sa with a value of $30.4M, Galapagos Nv with a value of $29.6M, Bridge Bio Pharma, Inc. with a value of $27.7M, Ab Cellera Biologics Inc. with a value of $23.5M, and Meira G Tx Holdings PLC with a value of $20.4M.

Examining the 13F form we can see an increase of $52.2M in the current position value, from $320M to 372M.

Prosight Management, LP is based out at Dallas, TX

Below you can find more details about Prosight Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $372 Million
Healthcare: $372 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 47
  • Current Value $372 Million
  • Prior Value $320 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 12 stocks
  • Additional Purchases 17 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.